Stay up-to- date with news from the CMSC Meeting in June 2016
Couldn’t make it to the congress? We are very happy to provide you with meeting coverage from the 2016 Annual Meeting of the CMSC, which is the largest North American meeting on MS with typically over 2000 delegates in attendance:
Watch the interview with Dr. Jerry Wolinsky: “Highlights of the John Whitaker Memorial lecture”
Read conference reports on:
- Real-World Assessment of Disease-Modifying Drugs (poster presentation by Chris Kozma)
- The Influence of Lifestyle Factors on MS (presentation by Allen Bowling)
- The Importance of Lipids in MS (presentation by John Nieland)
- Use of MRI as a Monitoring Tool (presentation by Gavin Giovannoni)
- Updates in Disease Management (presentation by Annette Okai)
A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study
Enrico Montanari, Mariarosa Rottoli, Davide Maimone, Paolo Confalonieri, Katrin Plewnia, Maura Frigo, Ada Francia, Antonello Pala, Nunzia Alessandra Losignore, Paolo Ragonese, Antonella Veneziano, on behalf of the POSIDONIA study group.
Journal of the Neurological Sciences, May 2016, Pages 105 - 109
Autoimmunity Reviews, Volume 15, Issue 7, July 2016, Pages 714–718
Distribution-based estimates of minimum clinically important difference in cognition, arm function and lower body function after slow release-fampridine treatment of patients with multiple sclerosis
H.B. Jensen, Sepehr Mamoei, M. Ravnborg, U. Dalgas, E. Stenager
Multiple Sclerosis and Related Disorders, Volume 7, May 2016, Pages 58–60
Daytime sleepiness versus fatigue in patients with multiple sclerosis: A systematic review on the Epworth sleepiness scale as an assessment tool
Roland F.J. Popp, Anna K. Fierlbeck, Helge Knüttel, Nicole König, Rainer Rupprecht, Robert Weissert, Thomas C. Wetter
Sleep Medicine Reviews, In Press, Corrected Proof, Available online 18 March 2016, Available online 18 March 2016
Short-term suboptimal response criteria for predicting long-term non-response to first-line disease modifying therapies in multiple sclerosis: A systematic review and meta-analysis
Jordi Río, Juan Luís Ruiz-Peña
Journal of the Neurological Sciences, February 2016, Pages 158 - 167
About the Editors
- Timothy Vartanian, Professor at the Brain and Mind Research Institute and the Department of Neurology, Weill Cornell Medical College, Cornell...
- Claire S. Riley, MD is an assistant attending neurologist and assistant professor of neurology in the Neurological Institute, Columbia University,...
- Rebecca Farber, MD is a Multiple Sclerosis fellow at The Corinne Goldsmith Dickinson Center for MS at Mount Sinai Hospital,...
- Jun 201622Jun 201625Boston, Massachusetts, USAThe congress of the Federation of Clinical Immunology Societies focuses on translational immunology, on molecular pathways and their implications in...Boston, United States
- Aug 201618Aug 201621
Advanced Education in Neurology in Asian Oceanian RegionKuala Lumpur, MalaysiaKuala Lumpur, MalaysiaThe Asian and Oceanian Congress of Neurology (AOCN), which is organized by the Malaysian Society of Neurosciences, is renowned for...
- Aug 201621Aug 201628Fort Lauderdale, Florida, USAThis 7-night Caribbean cruise conference is a round-trip starting from Fort Lauderdale. The conference sessions generally take place on days...Fort Lauderdale, United States